Prescription drug · ANDA
Amcinonide NDC 51672-4060
Amcinonide 1 mg/g · Ointment · Topical · Sun Pharmaceutical Industries, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51672-4060-1 | 51672406001 | 1 TUBE in 1 CARTON (51672-4060-1) / 15 g in 1 TUBEMarketed from Mar 19, 2003 | |
| 51672-4060-2 | 51672406002 | 1 TUBE in 1 CARTON (51672-4060-2) / 30 g in 1 TUBEMarketed from Mar 19, 2003 | |
| 51672-4060-3 | 51672406003 | 1 TUBE in 1 CARTON (51672-4060-3) / 60 g in 1 TUBEMarketed from Mar 19, 2003 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Amcinonide
- Generic name (nonproprietary)
- amcinonide
- Active ingredients
- Amcinonide — 1 mg/g
- Dosage form
- Ointment
- Route
- Topical
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 076367
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 51672-4060_31e404cb-aac7-730b-e063-6394a90afc03SPL ID 31e404cb-aac7-730b-e063-6394a90afc03SPL set ID ac5c3e79-52f7-434e-92ae-24bd32b45edcRxCUI 197327, 197328UNII 423W026MA9
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451672406001followed by a unit qualifier and the quantityPackage 51672-4060-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Excerpt only. Read the full label for complete information.